Læknaneminn - 01.10.1996, Page 79

Nýmyndun æöa og krabbamein - bylting í krabbameinslyfjameöferð innan seilingar?
HEIMILDIR
1. Ferrara N: The role of vascular endothelial growth factor in pat-
hological angiogenesis. Breast Cancer Res Treatment 36: 127-137,
1995.
2. Klagsbrun M, D’Amore P.A: Regulators of angiogenesis. Annu Rev
Physiol 53: 217-239, 1991.
3. Folkman J: How is blood vessel growth regulated in normal and
neoplastic tissue? - G.H.A. memorial award lecture. Cancer Res 46:
467-473, 1986.
4. Le Querrec A, Duval D, Tobelem G: Tumour angiogenesis. Bailli-
eres Clin Haematol 6(3): 711-730, 1993.
5. Rak J.W, St Croix B.D, Kervel R.S: Consequences of angiogenesis
for tumor progression, metastasis and cancer therapy. Anti-Cancer
Drugs 6: 3-18, 1995.
6. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other
disease. Nature Medicine 1: 27-31,1995.
7. Waleh NS, Brody MD, Knapp MA, Mendonca HL, Lord EM,
Koch CJ, Laderoute KR, Sutherland RM: Mapping og the vascular
endothelial growth factor-producing hypoxic cells in multicellular
tumor spheroids using a hypoxia-specific marker. Cancer Res 55:
6222-6226, 1995.
8. Toi M, Inada K, Suzuki H, TominagaT: Tumor angiogenesis in bre-
ast cancer: Its importance as a prognostic indicator and the associ-
ation with vascular endothelial growth factor expression. Breast
Cancer Res Treatment 36: 193-204, 1995.
9. Folkman J: The influence of angiogenesis research on management
of patients with breast cancer. Breast Cancer Res Treatment 36:
109-118, 1995.
10. Siitonen SM, Haapasalo HK, Rantala IS, Helin HJ, Isola JJ:
Comparison of dirrerent immunohistochemicaal methods in the
assessment of angiogenesis: lack of prognostic value in a group of 77
selected node-negative breast carcinomas. Mod Pathol 8(7): 745-
752, 1995.
11. Goulding H, Abdul Rashid NF, Robertson JF, Bell JA, Elston CW,
Blamey RW, Ellis IO: Assessment of angiogenesis in breast carcin-
oma: an imprtant factor in prognosis? Hum Pathol 26(11): 1196-
2000, 1995.
12. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore
DH, Meli S, Gasparini G: Tumor angiogenesis: a vew signiFicant
and independent prognostic indicator in early-stage breast carcin-
oma. J Natl Cancer Inst 84: 1875-1887,1992.
13. O’Reilly M.S, Holmgren L, Yuen S, Chen C, Rosenthal RA, Moses
M, Lane WS, Cao Y, Sage EH, Folkman J: Angiostatin: a novel
angiogenesis inhibitor that mediates the suppression of metastases
by a Lewis lung carcinoma. Cell 79: 315-328, 1994.
14. Murray C: Tumour dormancy: not so sleepy after all. Nature Med
1(2): 117-118, 1995.
15. Fikler I.J, Ellis L.M: The implications of angiogenesis for the biol-
ogy and therapy of cancer metastasis. Cell 79: 185-188, 1994.
16. Svenska Dagbladet, 12.9. 1995
17. Ingber D, Fujita T, Kishimoto S, Sudo K, Kanamaru T, Brem H,
Folkman J: Synthetic analogues of fumagillin that inhibit ang-
iogenesis and suppress tumour growth. Nature 348: 555-557,
1990.
18. Koto T, Sato K, Kakinuma H, Matsuda Y: Enhanced Suppression
of tumor growth by combination of angiogenesis inhibitor O-
(Chloroacetyl-carbamoyl)fumagillol (TNP-470) and cytotoxic
agents in mice. Cancer Res 54: 5143-5147,1994.
19. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferr-
ara N: Inhibition of vascular endothelial growth factor-induced
angiogenesis suppresses tumour growth in vivo. Nature 362: 841-
844, 1993.
20. Dameron KM, Volpert KV, Tainsky MA, Bouk NP: Control of
angiogenesis in fibroblasts by p53 regulation of thrombospondin-1.
Science 265: 1582-1584,1994.
LÆKNANEMINN
69
2. tbl. 1996, 49. árg.